loadpatents
name:-0.022457122802734
name:-0.010227203369141
name:-0.010933876037598
Haber; Lauric Patent Filings

Haber; Lauric

Patent Applications and Registrations

Patent applications and USPTO patent grants for Haber; Lauric.The latest application filed is for "multispecific antigen-binding molecules for cell targeting and uses thereof".

Company Profile
10.9.17
  • Haber; Lauric - Rye Brook NY
  • Haber; Lauric - San Carlos CA
  • Haber; Lauric - Tarrytown NY
  • Haber; Lauric - White Plain NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
Grant 11,453,721 - Murphy , et al. September 27, 2
2022-09-27
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof
App 20220251244 - Haber; Lauric ;   et al.
2022-08-11
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bind PSMA and CD3, and Uses Thereof
App 20210403595 - Kirshner; Jessica R. ;   et al.
2021-12-30
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
Grant 11,155,633 - Kirshner , et al. October 26, 2
2021-10-26
Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
App 20210253701 - Smith; Eric ;   et al.
2021-08-19
Anti-MUC16 antibodies
Grant 10,941,208 - Haber , et al. March 9, 2
2021-03-09
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof
App 20210047438 - Haber; Lauric ;   et al.
2021-02-18
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof
App 20200376136 - Rudge; John ;   et al.
2020-12-03
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20200317810 - Haber; Lauric ;   et al.
2020-10-08
EGFR x CD28 MULTISPECIFIC ANTIBODIES
App 20200299388 - Skokos; Dimitris ;   et al.
2020-09-24
Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
Grant 10,772,972 - Rudge , et al. September 15, 2
2020-09-15
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
Grant 10,738,130 - Haber , et al. A
2020-08-11
Bispecific Anti-muc16 X Anti-cd28 Antibodies And Uses Thereof
App 20200199233 - Murphy; Andrew J. ;   et al.
2020-06-25
Bispecific Anti-psma X Anti-cd28 Antibodies And Uses Thereof
App 20190389951 - Murphy; Andrew J. ;   et al.
2019-12-26
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
Grant 10,179,819 - Kirshner , et al. Ja
2019-01-15
Optimized Anti-CD3 Bispecific Antibodies and Uses Thereof
App 20180355038 - Smith; Eric ;   et al.
2018-12-13
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20180118848 - Haber; Lauric ;   et al.
2018-05-03
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20180112001 - Haber; Lauric ;   et al.
2018-04-26
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof
App 20180104357 - Rudge; John ;   et al.
2018-04-19
Anti-HER antibodies
Grant 9,327,035 - Fuh , et al. May 3, 2
2016-05-03
Anti-her Antibodies
App 20140193414 - Fuh; Germaine ;   et al.
2014-07-10
Anti-her Antibodies
App 20140056899 - Fuh; Germaine ;   et al.
2014-02-27
Multispecific anti-HER antibodies
Grant 8,597,652 - Fuh , et al. December 3, 2
2013-12-03
Bispecific Anti-her Antibodies
App 20120121596 - Fuh; Germaine ;   et al.
2012-05-17
Anti-her Antibodies
App 20100255010 - Fuh; Germaine ;   et al.
2010-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed